---
title: "Reverse Aging Trials"
url: https://alsuprun.com/blog/reverse-aging/reverse-aging-trials/
author: "Editorial"
date: 2026-10-08T18:52:31+00:00
categories: ["reverse aging"]
tags: []
---

# Reverse Aging Trials

The latest frontier in measurable age reversal is partial cellular reprogramming. Scientists have developed transcription factors that can reset cells’ biological clocks without modifying their genetic code.

 One of these drugs, called ER-100, has recently started human clinical trials for glaucoma—it’s intended to regenerate optic nerve cells and restore sight. But can this approach actually turn back time on our aging bodies?

 

## 1. Senolytics

 Senescent cells accumulate in the body over time and secrete harmful molecules that contribute to arthritis, osteoporosis, glaucoma, Alzheimer’s disease, and other age-related conditions and afflictions. They also increase susceptibility to infection with pathogens such as COVID-19. Senolytics are drugs that destroy senescent cells, restoring youthful function and eliminating harmful metabolites. A growing number of clinical trials are exploring senolytic compounds that have shown promise in treating age-related diseases and conditions.

 [![Rejuvenate your whole body & balance your health without medications - now remotely!](https://alsuprun.com/blog/wp-content/uploads/BioresonanceTopAd.png)](https://www.bioresonance.rent) Researchers have found that senolytics can significantly reduce symptoms of aging and chronic disease in mouse models. They have also demonstrated that senolytics can extend lifespan, and they are currently evaluating whether these compounds will improve quality of life in human volunteers.

 The development of senolytics is challenging because senescent cells can be difficult to distinguish from normal, healthy cells. To identify senolytics, scientists use high-throughput screens to screen compounds against cell populations induced to senescence using various stimuli. These screens are used to identify compounds that kill the senescent cells. However, the results of this kind of testing can be misleading because senolytics may also kill non-senescent cells.

 In addition, senescent cells are heterogeneous, and not all types of senescent cells are created equal. For example, some senescent cancer cells become polyploid and acquire stem cell-like properties, self-renewal, and resistance to chemotherapy. These senescent cancer cells are referred to as “tumor-initiating senescence” (TIS). To avoid this problem, scientists are developing methods to better distinguish TIS senescent cells from non-TIS senescent cells.

 [![](https://alsuprun.com/blog/wp-content/uploads/ForeverYoungYouWannaBe.png)](https://alsuprun.com/services.html#Contact) A recent study showed that the compound navitoclax can bind to senescent cancer cells and kill them without damaging surrounding, normal cells. It was discovered that navitoclax targets the enzyme BRCA1, which is involved in DNA repair and senescence control. This is a promising lead for future senolytics.

 In order to advance this approach, researchers need a better understanding of the cellular mechanisms that regulate senescence and senomorphics. They also need to develop ways to improve targeting and minimize off-target effects. For instance, they are looking at antibody-drug conjugates, nanoparticles, and tissue-specific prodrugs to optimize targeting and delivery. Furthermore, they are examining the use of natural plant-based compounds as senolytics. Despite the many challenges, this research holds promise as a paradigm shift in aging and chronic disease treatment.

 

## 2. Reprogramming

 Reprogramming involves changing the cellular identity of somatic cells to become multipotent stem cells. These cells can then be reprogrammed into different cell types to treat specific conditions and illnesses. This has been achieved in mice, where it is believed to have helped restore the function of certain organs. Reprogramming is a complex process that requires the right set of chemicals, which are usually a combination of transcription factors. This process is used to create induced pluripotent stem cells (iPSCs), which can then be used for research or in therapy. The FDA recently cleared the first human trial of partial reprogramming, in which patients are given drugs to induce the conversion of some of their own cells into iPSCs that are specific to their condition.

 The success of reprogramming has opened new avenues for disease modeling, drug development, and regenerative/rejuvenation therapies. For example, reprogramming of fibroblasts has been shown to reduce lung fibrosis in age-accelerated mice, which is associated with the onset of respiratory failure. Reprogramming has also been used to rejuvenate skin and kidneys in older mice, which is thought to be an early indication that this technology can work in humans.

 One challenge is that some of the genes needed for reprogramming are expressed at low levels in mature somatic cells. However, researchers have developed a number of approaches to increase the expression of these genes. One method is to use viruses to deliver the reprogramming factors. This has been shown to be effective in converting fibroblasts into iPSCs, but it has not been as successful when used to convert other types of somatic cells.

 Another method is to use chemical cocktails to initiate reprogramming. In recent years, this has been used to generate iPSCs from mouse and human fibroblasts. These iPSCs have been shown to have similar properties to embryonic stem cells, but they are generated from a patient’s own cells and therefore can avoid the risk of immunological rejection of transplanted cells.

 [![](https://alsuprun.com/blog/wp-content/uploads/RadionicMerch.png)](https://alsuprun.com/merch.html) Direct reprogramming is also being tested in human trials. A recent study showed that direct reprogramming of cardiac fibroblasts into cardiomyocytes could be accomplished with a cocktail of reprogramming factors, including GATA4, TBX5 and a transcription-hyperactive form of MEF2C. In addition, this study showed that reprogramming was accelerated on substrates with nano-topographical cues, such as grooves and nanoparticles.

 

## 3. Stem cells

 Stem cells are the source of regenerative cells that give rise to specialised cells that replace damaged or worn-out tissue and organs. The ability of stem cells to produce new tissues and organs enables us to repair the damage caused by injury or illness and may prolong life.

 Stem cell therapy involves using stem cells to treat a variety of conditions, including osteoarthritis, skin disease and cardiovascular disease. Stem cells can also stimulate the production of growth factors that enhance natural healing processes. These factors can reduce signs of aging, such as wrinkles and age spots, improve cellular energy levels, increase skin elasticity and promote hair growth.

 Different types of stem cells have different functions, but all have the capacity to differentiate into specialized cells. Stem cells are able to regenerate and replace damaged tissue and can be used in transplant and regenerative medicine. They are also being used to test the safety and efficacy of drugs in pre-clinical trials.

 Scientists are studying naturally occurring stem cells to learn how they function and why they sometimes turn into cancer cells. They are also working to create more powerful regenerative therapies. One such approach involves resetting the cellular “biological clock” by adding specific transcription factors. This technique was pioneered by Japanese researcher Shinya Yamanaka, who won the 2012 Nobel Prize for his work.

 Many studies involve embryonic stem cells, which have the potential to become any type of cell in the body. However, there are many ethical concerns about the use of these cells. Scientists are also experimenting with adult stem cells. These can be found in bone marrow, adipose tissue and the skin.

 Stem cells can be administered to patients in two ways, either via a systemic injection or locally at the site of a diseased area. In the case of local injections, the supernatant from culturing the stem cells is injected directly into the site of the problem. The injected cells will then migrate to the damaged tissue and repair it. The resulting repair process may help alleviate the symptoms of the disease and prolong the life of the patient.

 

## 4. Vaccines

 A vaccine is an injection that primes the body’s immune system to attack and destroy disease-causing microbes. Vaccines are among the most effective public health tools, helping to reduce morbidity and mortality from both endemic and emergent diseases. They also provide a powerful model for how a healthy and stable population can fend off disease through the principles of herd immunity.

 Vaccines target a particular antigen, or a piece of a pathogen, to stimulate the production of antibodies that attack the specific threat. Then the immune system recognizes and remembers these “memory” antibodies, so that it is ready to quickly respond to a future infection with the same antigen. Vaccines often require boosters, or supplementary doses, to maintain immunity.

 The latest vaccines are targeting senescent cells (SC), pro-inflammatory and toxic cells that accumulate in many age-related pathologies, such as atherosclerosis, fibrosis, diabetes and more. These vaccines can remove senescent cells, or induce their reprogramming into pro-growth, repair, or tissue-protective cells. However, determining which SCs to target and how to trigger their reprogramming remain challenging obstacles. One company, Life Biosciences, is developing a cellular-rejuvenation therapy called ER-100, which is the first to get FDA approval to enter clinical trials and test whether it can ameliorate human disease by eradicating senescent cells.

 It is not clear how the ER-100 vaccine works, but it targets senescent cells by combining a peptide with a monoclonal antibody that specifically recognizes senescent CD153 cells. The resulting immunotherapy has been shown to attenuate atherosclerotic plaque growth and improve glucose metabolism in mice, and is in early-stage development for use in humans.

 Vaccines prepare your body’s immune system to fight infections, and they can do much more. In a study of 3,800 people over age 60, researchers found that shingles vaccine recipients exhibited lower levels of background inflammation and slower molecular aging than those who did not receive the vaccine. The results were consistent even after accounting for health and demographic differences. The results are the strongest evidence to date that vaccination may help support healthier aging, but further studies are needed.

```json
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Reverse Aging Trials",
    "url": "https://alsuprun.com/blog/reverse-aging/reverse-aging-trials/",
    "datePublished": "2026-10-08T18:52:31+00:00",
    "dateModified": "2026-10-08T18:52:41+00:00",
    "author": {
        "@type": "Person",
        "name": "Editorial"
    },
    "publisher": {
        "@type": "Organization",
        "name": "Information Wellness Blog",
        "url": "https://alsuprun.com/blog/"
    }
}
```